After building Ochre Bio, Jack O’Meara’s newest biotech raises $21M for neuro siRNAsnews2025-10-01T11:00:29+00:00October 1st, 2025|Endpoints News|
Crystalys lands $205M to bring gout drug first marketed in Japan to the US and Europenews2025-09-30T12:00:17+00:00September 30th, 2025|Endpoints News|
Star gets $125M Series D as it begins Phase 3 in bleeding disordersnews2025-09-30T10:30:56+00:00September 30th, 2025|Endpoints News|
Mission BioCapital raises $134M for sixth biotech investment fundnews2025-09-26T17:51:40+00:00September 26th, 2025|Endpoints News|
Get your CVR: Backloaded acquisitions come into focus following Metsera, 89bio dealsnews2025-09-26T13:30:47+00:00September 26th, 2025|Endpoints News|
RA and Forbion back Sparrow’s $95M Series B for type 2 diabetes drugnews2025-09-24T12:30:41+00:00September 24th, 2025|Endpoints News|
Sanofi adds $625M to its corporate venture armnews2025-09-24T05:00:16+00:00September 24th, 2025|Endpoints News|
Avenzo collects another $60M for two small molecules and two ADCs licensed from Chinanews2025-09-22T13:00:50+00:00September 22nd, 2025|Endpoints News|
Endpoints 11 winner 2025: Chai Discovery aims to design drugs on the computernews2025-09-19T14:00:57+00:00September 19th, 2025|Endpoints News|
The 2025 winners of the Endpoints 11: Biotech’s most exciting startupsnews2025-09-19T14:00:57+00:00September 19th, 2025|Endpoints News|
